(Reuters Health) – A glass of red wine at dinner is safe and possibly beneficial for people with type 2 diabetes, a new trial suggests. People who followed a healthy diet and drank a glass of red wine at dinner for two years ended up with better HDL or “good” cholesterol and other good health-related […]

A new blood test might help doctors figure out faster whether someone’s having a heart attack. The test reliably told doctors which patients were not having heart attacks after only one blood sample, compared to the current method that requires several hours and multiple blood samples, researchers found. “The ultimate goal would be to have […]

A biotech company founded by a Nobel prize winner has won the go-ahead from European regulators to begin the application process for conditional marketing authorization of a stem cell-based regenerative heart treatment. Conditional approval, if granted, would allow Cardiff-based Cell Therapy to start selling its Heartcel product for regenerating damaged areas of heart while continuing […]

A prototype patch could help repair the damage caused by a heart attack, scientists say. The early work, carried out on mice and pigs, reveals the protein-infused patch encourages the growth of healthy cells and leads to less scarring. Scarring can be common after a heart attack, making the heart pump less effectively and sometimes […]

NEW HAVEN, Conn., Sept. 8, 2015 /PRNewswire/ — New Haven Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, today announced that the U.S. Food and Drug Administration (FDA) has approved DURLAZA (aspirin), the first and only 24-hour, Extended Release Capsules, (162.5mg) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack). “DURLAZA […]

U.S. regulators have approved a new dose of AstraZeneca’s blood thinner Brilinta for longer-term use in patients with a history of heart attacks, boosting prospects for a drug the company thinks will eventually sell $3.5 billion a year. The green light from the U.S. Food and Drug Administration (FDA), announced late on Thursday, could theoretically […]

The U.S. Food and Drug Administration on Thursday approved Amgen Inc’s Repatha drug for patients with hereditary forms of high cholesterol and those with cardiovascular disease. Last month the FDA approved a similar drug from Regeneron Pharmaceuticals Inc and Sanofi SA. The drugs belong to a potent new class of injectable LDL-lowering drugs known as […]

New guidelines for prescribing cholesterol-lowering medications are efficient and cost-effective, according to two new studies. The new research, published in JAMA, examines the 2013 recommendation that people ages 40 to 75 with at least a 7.5 percent risk of having a heart attack or stroke over the next 10 years receive statin drugs. “We decide […]